Healthcare -
Biotechnology - NASDAQ - US
$ 110.05
5.87 %
$ 6.99 B
Market Cap
-52.66
P/E
BPMC - REVENUE
Revenue BPMC - Blueprint Medicines Corporation
249 M
LAST VALUE
17.68%
2 YEAR CAGR
41.14%
5 YEAR CAGR
0.00%
10 YEAR CAGR